Axonal transection in the lesions of multiple sclerosis BD Trapp, J Peterson, RM Ransohoff, R Rudick, S Mörk, L Bö New England Journal of Medicine 338 (5), 278-285, 1998 | 5048 | 1998 |
Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions JW Peterson, L Bö, S Mörk, A Chang, BD Trapp Annals of Neurology: Official Journal of the American Neurological …, 2001 | 1707 | 2001 |
Subpial demyelination in the cerebral cortex of multiple sclerosis patients L Bø, CA Vedeler, HI Nyland, BD Trapp, SJ Mørk Journal of Neuropathology & Experimental Neurology 62 (7), 723-732, 2003 | 869 | 2003 |
Neurological disability correlates with spinal cord axonal loss and reduced N‐acetyl aspartate in chronic multiple sclerosis patients C Bjartmar, G Kidd, S Mörk, R Rudick, BD Trapp Annals of neurology 48 (6), 893-901, 2000 | 733 | 2000 |
Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration L Bø, CA Vedeler, H Nyland, BD Trapp, SJ Mørk Multiple Sclerosis Journal 9 (4), 323-331, 2003 | 594 | 2003 |
Ependymoma. A follow‐up study of 101 cases SJ Mørk, AC Løken Cancer 40 (2), 907-915, 1977 | 459 | 1977 |
Class III β‐tubulin in human development and cancer CD Katsetos, MM Herman, SJ Mörk Cell motility and the cytoskeleton 55 (2), 77-96, 2003 | 375 | 2003 |
Pathogenesis of tissue injury in MS lesions BD Trapp, L Bö, S Mörk, A Chang Journal of neuroimmunology 98 (1), 49-56, 1999 | 369 | 1999 |
Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions L Bö, S Mörk, PA Kong, H Nyland, CA Pardo, BD Trapp Journal of neuroimmunology 51 (2), 135-146, 1994 | 338 | 1994 |
Class III β-tubulin isotype: a key cytoskeletal protein at the crossroads of developmental neurobiology and tumor neuropathology CD Katsetos, A Legido, E Perentes, SJ Mörk Journal of child neurology 18 (12), 851-866, 2003 | 305 | 2003 |
Oligodendroglioma: incidence and biological behavior in a defined population SJ Mørk, KF Lindegaard, TB Halvorsen, EH Lehmann, T Solgaard, ... Journal of neurosurgery 63 (6), 881-889, 1985 | 296 | 1985 |
Fish protein hydrolysate reduces plasma total cholesterol, increases the proportion of HDL cholesterol, and lowers acyl-CoA: cholesterol acyltransferase activity in liver of … H Wergedahl, OA Gudbrandsen, Z Muna, RK Berge, B Liaset, E Lied, ... The Journal of nutrition 134 (6), 1320-1327, 2004 | 294 | 2004 |
Primary intraspinal neoplasms in Norway, 1955 to 1986: a population-based survey of 467 patients A Helseth, SJ Mørk Journal of neurosurgery 71 (6), 842-845, 1989 | 282 | 1989 |
Expression of oligodendrocyte progenitor cell antigens by gliomas: implications for the histogenesis of brain tumors Y Shoshan, A Nishiyama, A Chang, S Mörk, GH Barnett, JK Cowell, ... Proceedings of the National Academy of Sciences 96 (18), 10361-10366, 1999 | 236 | 1999 |
Reactive microglia in multiple sclerosis lesions have an increased expression of receptors for the Fc part of IgG E Ulvestad, K Williams, C Vedeler, J Antel, H Nyland, S Mørk, R Matre Journal of the neurological sciences 121 (2), 125-131, 1994 | 205 | 1994 |
Grey matter pathology in multiple sclerosis L Bö, JJG Geurts, SJ Mörk, P Van Der Valk Acta Neurologica Scandinavica 113, 48-50, 2006 | 197 | 2006 |
Distribution of immunoglobulin superfamily members ICAM-1,-2,-3, and the β2 integrin LFA-1 in multiple sclerosis lesions L Bö, JW Peterson, S Mørk, PA Hoffman, WM Gallatin, RM Ransohoff, ... Journal of Neuropathology & Experimental Neurology 55 (10), 1060-1072, 1996 | 191 | 1996 |
Panel review of anaplastic oligodendroglioma from European Organization For Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p … JM Kros, T Gorlia, MC Kouwenhoven, PP Zheng, VP Collins, ... Journal of Neuropathology & Experimental Neurology 66 (6), 545-551, 2007 | 185 | 2007 |
Neoplasms of the central nervous system in Norway: IV. A population‐based epidemiological study of meningiomas ARE HELSETH, SJ MØRK, A JOHANSEN, S TRETLI Apmis 97 (7‐12), 646-654, 1989 | 157* | 1989 |
EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis KM Talasila, A Soentgerath, P Euskirchen, GV Rosland, J Wang, ... Acta neuropathologica 125, 683-698, 2013 | 156 | 2013 |